Medications & Supplements/Prescription Drugs

RemedyRepack Rifampin Capsules Recalled for Impurity and Degradation Standards

Agency Publication Date: January 6, 2023

Summary

RemedyRepack Inc. has recalled 132 blister cards of Rifampin Capsules (300 mg), which were repackaged from medication originally manufactured by Lupin Pharma. The recall was initiated because the tablets failed to meet required standards for impurities and degradation. No incidents or injuries related to this recall have been reported.

Risk

The medication may contain impurities or have broken down over time, which can compromise the drug's safety and effectiveness. If the medication is not as effective as intended, it may not properly treat the patient's condition.

What You Should Do

This recall involves Rifampin Capsules (300 mg) sold in 30-count blister cards with repackaged NDC 70518-2404-00 and original NDC 68180-0659-07.
Check your medication for lot numbers J0599794-022322 (expiration date 02/28/2023) or J0621369-052622 (expiration date 06/30/2023) printed on the packaging.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact RemedyRepack Inc. directly for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Rifampin Capsules (300 mg)

Variants: 300 mg, 30 count blister card

Lot Numbers:

J0599794-022322 (Exp 02/28/2023)

J0621369-052622 (Exp 06/30/2023)

NDC:

70518-2404-00

68180-0659-07

Repackaged by RemedyRepack Inc.; Original Mfg: Lupin Pharma, Baltimore, MD 21202.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 91345

Status: Resolved

Manufacturer: RemedyRepack Inc.

Sold By: One account in PA

Manufactured In: United States

Units Affected: 132 Cards of 30 = 3960 Tablets

Distributed To: Pennsylvania

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall involves Rifampin Capsules (300 mg) sold in 30-count blister cards with repackaged NDC 70518-2404-00 and original NDC 68180-0659-07.

Check your medication for lot numbers J0599794-022322 (expiration date 02/28/2023) or J0621369-052622 (expiration date 06/30/2023) printed on the packaging.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact RemedyRepack Inc. directly for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.